Item 8.01. Other Events.

On January 7, 2021, PerkinElmer, Inc. (the "Company") and Oxford Immunotec Global PLC ("Oxford") issued a joint announcement announcing the execution of an Implementation Agreement (the "Implementation Agreement") by and among the Company, Oxford and PerkinElmer (UK) Holdings Limited, under which the Company will acquire Oxford (the "Acquisition") on the terms and conditions therein. A copy of the joint announcement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

© Edgar Online, source Glimpses